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Abstract
Background: This study aimed to ask a sample of the general population about their preferences
regarding doctors holding discretionary powers in relation to disclosing cancer diagnosis and
prognosis.
Methods: The researchers mailed 443 questionnaires to registered voters in a ward of Tokyo
which had a socio-demographic profile similar to greater Tokyo's average and received 246
responses (response rate 55.5%). We describe and analysed respondents' attitudes toward doctors
and family members holding discretionary powers in relation to cancer diagnoses disclose.
Results: Amongst respondents who wanted full disclosure about the diagnosis without delay, 117
(69.6 %) respondents agreed to follow the doctor's discretion, whilst 111 (66.1 %) respondents
agreed to follow the family member's decision. For respondents who preferred to have the
diagnosis and prognosis withheld, 59 (26.5 %) agreed to follow the doctor's decision, and 79 (35.3
%) of respondents agreed with following family member's wishes.
Conclusions: The greater proportion of respondents wants or permits disclosure of cancer
diagnosis and prognosis. In patients who reveal negative attitudes toward being given a cancer
disclosure directly, alternative options exist such as telling the family ahead of the patient or having
a discussion of the cancer diagnosis with the patient together with the family. It is recommended
that health professionals become more aware about the need to provide patients with their cancer
diagnosis and prognosis in a variety of ways.
Background
Cancer ranks as the third leading cause of death world-
wide, accounting for approximately 12 % of all recorded
deaths [1]. As cancer is sometimes fatal and its treatment
often involves invasive medical procedures and medica-
tion, it has a great impact on patients' lives. The extent to
which physicians should inform patients of their diagno-
sis and prognosis poses a difficult decision in clinical
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diagnosis is not routinely disclosed in many cultures in
Africa [2], Eastern and Southern Europe [3-6], and the
Middle East [7]. Even in the United States, where most
doctors follow informed consent guidelines which
includes informing patients of their diagnosis as standard
clinical practice, problems still exist regarding the accurate
provision of prognosis information [8].
In Japan, historically, physicians have withheld discussing
cancer diagnoses directly with patients [9]. However, since
the early 1990s, due to the increased understanding and
adoption of informed consent policy and practice, physi-
cians have gradually begun to inform patients of their can-
cer diagnosis in clinical practice [10,11]. In many cases,
however, details regarding prognosis are still concealed
from patients, especially if the condition is incurable
[12,13]. While some physicians provide full information
from the outset, others provide no information at all, even
withholding basic diagnosis information [14]. The
National Cancer Centre (The core national institution for
developing cancer treatment, research and policy) has
compiled a set of guidelines for cancer disclosure. How-
ever, each hospital has deferring policy and practice [9].
No law or regulation stipulates that doctors are required
to obtain informed consent from patients. Given this con-
text, there are demonstrated needs to develop concrete
guidelines and to promote cancer disclosure based on
patients' preferences.
In Japan, the patient, family and doctor are the main play-
ers in cancer disclosure. According to legal precedents in
Japan, doctors are given a wide range of discretionary
powers regarding disclosure [14-16]. As a rationale for
holding discretionary power, doctors report a number of
compelling reasons such as the need to protect patients
from psychological distress caused by disclosure of the
diagnosis, families' wishes for non-disclosure to patients,
and the fact that most patients themselves do not wish to
be told the truth [9,17,18]. However, several case-control
studies report that there is no relationship between cancer
disclosure and mental harm [19-21]. As family members
are more reluctant than patients to disclose the truth
[11,22], patients' needs for information are often unsatis-
fied in Japan where physicians often discuss the cancer
diagnosis with family prior to informing the patient
[23,24]. Doctors' discretionary powers and families' pow-
ers of attorney need to be reconsidered in the light of
patients' preferences. This study's aim was to ask the gen-
eral population whether they, in the event of developing
cancer, preferred doctors' (or family members') discre-
tionary powers regarding disclosure of the cancer diagno-
sis and prognosis.
Methods
This study was a cross-sectional, stratified random sam-
pling survey of the general population in their 40s to 50s.
As people over 60 years old are epidemiologically more at
risk of having cancer, we excluded them not only because
it seemed harmful to ask about these experiences, but also
because there was a possibility that their responses would
be affected by their experiences. Participants were selected
from eligible voters in 'A' ward in the Tokyo Metropolitan
Area. We chose 'A' ward as a representative area of Tokyo
because various social indices such as the proportion of
the elderly population, average length of education, and
population growth rate were consistent with the Tokyo
average [25]. The researchers mailed 443 questionnaires
in October 2002 and received 246 responses (response
rate 55.5 %). Amongst the respondents, 26 (10.5%) peo-
ple had been diagnosed with cancer sometime in the past.
As there were no significant differences in the responses of
those who had been diagnosed with cancer and those who
had not, we included these 26 respondents in the analysis.
There were also no significant differences between those
who were relatives of a cancer patient or were not and
those who had dealt with cancer in their role as medical
staff or had not. The sample size was determined by the
need to provide adequate numbers to be able to detect dif-
ferences among disclosure preferences with some degree
of statistical certainty.
The questionnaire was developed in consultation with 6
medical staff and 19 patients. The questionnaire pre-
sented a hypothetical scenario in which "The doctor dis-
covers terminal cancer, but the patient does not know
yet." to each respondent, and asked about preferences
regarding diagnosis and prognosis disclosure; "How
would you want to be told, if you were in such a situa-
tion". Answer choices for disclosure preferences regarding
diagnosis were: 1."I would not want to be given any infor-
mation regarding my diagnosis [non-disclosure]", 2. "I
would like to obtain information regarding my diagnosis
of a general nature but not in detail" 3." "I would like to
be given all information regarding my diagnosis [full-dis-
closure]". Choices for disclosure on the prospects of com-
plete recovery (CR) and expected length of survival (LS)
were: 1. "I would not want to be given any information
about the prospects of CR and LS [non-disclosure]", 2." I
would like to obtain information on the prospects of CR
and LS of a general nature but not in detail. [partial-disclo-
sure]", 3. "I would like to be told about my prospects of
CR and LS eventually. However, I would like to receive
only general information on the prospects of CR (LS)
when I am initially informed about the disease [post-
poned full-disclosure]", and 4. "I would like to be told
about my prospects of CR and LS without delay. [immedi-
ate full-disclosure]". The reason for providing s answers
allowing partial-disclosure was based on research byPage 2 of 6
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accustomed to and commonly preferred ambiguous or
graded answers rather than polarised ones.
Respondents were asked about their attitudes toward doc-
tors and family members holding discretionary powers
regarding cancer diagnosis disclosure. In order to compare
the attitudes and characteristics of respondents who pre-
ferred immediate diagnosis and prognosis and those who
did not, analysis was carried out twice. In the first analysis
we included respondents who did not choose "full diag-
nosis and prognosis without delay", and we included the
data from the remaining respondents that explained the
reason for allowing to receive immediate diagnosis and
prognosis. In the second analysis we included respond-
ents who did want to receive diagnosis and prognosis, and
we included data from the rest of the respondents about
their reasons for preferring the withholding of diagnosis
and prognosis. We also asked about preferences regarding
the cancer disclosure process, such as whether people
would like to obtain information ahead of their family.
The questionnaire also included the trait part of the Japa-
nese version of the State-Trait Anxiety Inventory (STAI),
which assesses the personality predisposition to anxiety
[27-29]. The Japanese version of STAI is a widely used and
standardized test. In the present sample, the trait part of
STAI for Cronbach's α = 0.90.
Firstly, we calculated all respondents' disclosure prefer-
ences regarding diagnosis, CR and LS. Secondly, we calcu-
lated the attitudes toward doctors and family members
holding prognosis discretion of respondents who pre-
ferred to be given diagnosis information directly, and
those who did not. Wilcoxon's test was used to examine
the differences between the attitudes held toward doctors
and family members holding discretionary powers
between these two groups. Statistical analyses were con-
ducted using SPSS Version 11.5J.
Results
The socio-demographic characteristics of the respondents
are shown in Table 1. The mean age of the 246 respond-
ents was 49.8 years (± 6.2 years). More than half (N = 143:
58.1 %) were female, 78 (31.7 %) had graduated from
college, and 32 (13.0 %) were living alone.
Respondents' preferences regarding diagnosis and prog-
nosis disclosure are shown in Table 2. Regarding diagno-
sis, 85.4 % of respondents wanted full-disclosure, 11.3 %
wanted partial disclosure and 2.9 % wanted non-disclo-
sure. In the case of the prospect of a complete recovery;
35.7 % of respondents wanted an immediate full-disclo-
sure, 17.2 % wanted a postponed full-disclosure, 39.2 %
wanted partial-disclosure, and 2.9 % wanted no disclo-
sure. Regarding the expected length of survival; 32.2 % of
respondents wanted an immediate full-disclosure, 11.4 %
wanted a postponed full-disclosure, 50.0 % wanted par-
tial-disclosure, and 6.4 % wanted no disclosure.
Table 1: Characteristics of the respondents. (N = 246)
Mean SD
Age (yr) 49.8 6.2
STAI (total score) 41.4 9.9
N %
Sex (female) 143 58.1 %
College graduates 78 31.7 %
Living alone 32 13.0 %
Married 186 75.6 %
Living with adult child 85 26.1 %
Living with infant child 98 39.8 %
Principal household earner 133 54.1 %
Non-religious 185 75.2 %
Table 2: Disclosure preferences regarding diagnosis and prognosis
Non-disclosure Partial-disclosure Full-disclosure
Diagnosis (N = 239) 7 (2.9 %) 27 (11.3 %) 204 (85.4%)
Non-disclosure Partial-disclosure Postponed Full-disclosure Immediate Full-disclosure
Prospect of Complete 
recovery (N = 238)
7 (2.9 %) 105 (39.2 %) 41 (17.2 %) 85 (35.7 %)
Expected Length of Survival 
(N = 236)
15 (6.4 %) 118 (50.0 %) 27 (11.4 %) 76 (32.2 %)Page 3 of 6
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diagnosis and prognosis information without delay, 117
(69.6 %) respondents agreed to follow the doctor's initia-
tive and 111 (66.1 %) of the respondents agreed to follow
the with family member's decision [Figure 1]. The Wil-
coxon test found no significant difference between these
two groups (z = 0.186, p = 0.853). As for the reason for
wanting the diagnosis and prognosis information to be
withheld, 59 (26.5 %) of the respondents agreed to follow
the doctor's initiative, and 79 (35.3 %) of respondents
agreed to follow family member's wishes [Figure 2]. Wil-
coxon test found significant differences between these two
groups (z = 6.470, p < 0.001).
Regarding the cancer disclosure process, more than half
the respondents (N = 136; 55.3 %) answered that they
would like to obtain diagnosis and prognosis information
ahead of their family, a third (N = 82: 32.3 %) answering
that would like to receive information with their family
together at the same time. Only 26 (32.3%) respondents
preferred to obtain this information after the doctor had
already informed their family.
Discussion
Regarding preferences relating to diagnosis and prognosis,
only 2.7 % of the respondents wanted no information
regarding a cancer diagnosis. In addition to considering to
tell or not to tell, the extent to which physicians should
inform patient of diagnosis and prognosis poses a difficult
decision in clinical settings. However, more than two-
thirds (68.7 %) wanted full diagnostic and general prog-
nostic information in a general nature but not in detail or
Preference for who should decide whether to give immediate diagnosis and prognosisFigu  1
Preference for who should decide whether to give immediate diagnosis and prognosis. N = 175.
Preferences for who should decide whether to withhold diagnosis and prognosisFigu  2
Preferences for who should decide whether to withhold diagnosis and prognosis. N = 240.Page 4 of 6
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than a third (28.9 %) wanted full information regarding
diagnosis and prognosis without delay. These results sug-
gest that a disclosure policy which provides patients with
full information on diagnosis and general information on
prognosis can satisfy the majority of patients' preferences.
The results also suggest that any disclosure policy should
also try to acknowledge and meet patients' wishes of being
informed together with their families, and of being given
information at a later time.
Nevertheless, some patients do not want any information
regarding their cancer diagnosis. In the clinical setting,
medical staff needs to develop policy and procedures that
can deal with the needs of patients who do not want any
information as well as those patients and who want com-
plete information immediately. The priority in identifying
these types of patients over-rides other factors which affect
patients preferences regarding diagnosis and prognosis
such as patient characteristics and seriousness of cancer
(previous research conducted by the authors [30]).
Regarding those respondents who did not want to be
given a diagnosis directly, those who preferred to follow a
family member's decision were significantly larger than
those who would prefer a doctor to decide. If patients
reveal negative attitudes toward being given a cancer diag-
nosis at the time of initial consultation and testing, it may
still be effective to tell the patient's family ahead of the
patient or to have a discussion of cancer disclosure
together with the family.
Despite the data that indicates a mix of patients' prefer-
ences regarding cancer diagnosis, it may not be necessary
for doctors to make choices regarding diagnosis by actu-
ally knowing individual patients' preferences. As opposed
to those who would prefer no information, a greater pro-
portion of respondents wanted to receive full informa-
tion, even contrary to their preferences. Two other surveys
with the general public show a similar tendency of
patients wanting more information regarding cancer diag-
nosis than they used to. Asahi Newspaper found that
regarding one's own cancer diagnosis and prognosis, in
1989, 59% of respondents wanted disclosure, which
increased to 76%) in 2000 [31]. Similarly, Yomiuri News-
paper found that in 1994, 70% of respondents preferred
being given information about a cancer diagnosis that
increased to 78% in 2001 [32]. Thus the importance of
providing information is widely supported by the major-
ity of the general community.
To simulate the fact that cancer results in a variety of dis-
ease outcomes for patients, we used scenarios with a range
of severities in the outcomes of the cancer. As a result,
there is little difference between respondents who had
experienced cancer disclosure as a patient and those who
did not, and the diagnosis preferences revealed in this
study (full-disclosure, 85.4%) are consistent with previ-
ous studies (Seo [18], 85.7%: Miura [33], 88.1%). These
findings suggest that this study's method succeeded in
simulating a situation that reflected some degree of reality
for respondents who had been given a cancer diagnosis in
the past.
This study has several limitations. Although the response
rate to this study was moderate for a general population
survey, we acknowledge that the characteristics of the
respondents might not be wholly representative of the
general population. Also, because we restricted partici-
pants to adult inhabitants in an urban area in Japan, fur-
ther research is required to test the validity of these
findings.
It is recommended that health professionals become more
aware about the need to provide patients with options to
be given their cancer diagnosis and prognosis in a variety
of ways. The greater proportion of respondents wants or
permits disclosure of cancer diagnosis and prognosis.
However, in patients who reveal negative attitudes toward
being given a cancer disclosure directly, alternative
options should be made available such as telling the fam-
ily ahead of the patient or having a discussion of the can-
cer diagnosis with the patient together with the family.
Further research with people aged over-sixty is needed to
test the applicability of these findings to older age groups.
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